© 2014 - 2022

ReMedDev® is a TM of

Vermilion Life Sciences Ltd


​​​​About Vermilion Life Sciences Ltd

Vermilion Life Sciences was founded by Stuart Dollow to deliver new models of medicines development. Our ambition is to cut the costs and time for medicines to reach patients by Reengineering Medicines Development #ReMedDev®. 

Stuart is a fully registered physician with the GMC who trained in General Medicine and General Practice before spending many years in senior leadership roles in large and medium sized pharmaceutical companies. Stuart is also Chair of the UK Government's Advisory Committee on Clinical Impact Awards

He was previously a member of the UK Government's Office for Life Sciences Expert Advisory Group on Innovative Medicines, leading a work stream on the Accelerated Access Review, designing the principles for NHS England's Accelerated Access Collaborative. He was also previously a Board Member of the UK's Human Tissue Authority and Board Trustee of the Faculty of Pharmaceutical Medicine. He is a strong motivator and strategic thinker, seeking and providing solutions beyond the obvious.

Vermilion Life Sciences offers and co-ordinates pro bono input and expertise to medical research charities through a network of experienced consultants with a range of skills and experience.

Vermilion Life Sciences. Reengineering Medicines Development #ReMedDev®

Please contact us to learn more.